Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Tolerance and Compliance Study With a High Caloric, High Protein Oral Nutritional Supplement in Nursing Home Residents - ad Libitum Intake

NCT02938234 is registered in ClinicalTrials.gov with Fresenius Kabi as lead sponsor.

NCT NCT02938234
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02938234 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Tolerance and Compliance Study With a High Caloric, High Protein Oral Nutritional Supplement in Nursing Home Residents - ad Libitum Intake
Lead sponsor
Fresenius Kabi
Phase
Not applicable
Overall status
Completed
Start date
September 30, 2016
Completion date
October 31, 2016
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

malnutrition